The DOI matches its Crossref record.
Cytoplasmic and Nuclear Delivery of a TAT-derived Peptide and a β-Peptide after Endocytic Uptake into HeLa Cells
Open accessAbstract
Several short, highly cationic peptides are able to enter the cytoplasm and nucleus of cells from the extracellular medium. The mechanism of entry is unknown. A number of fluorescence-based studies suggested that these molecules cross the plasma membrane by an energy-independent process, directly gaining access to the cytoplasm. Recent reports have questioned this conclusion, attributing the prior observations to artifacts resulting from fixation procedures used to prepare cells for fluorescence microscopy. These studies analyzed live cells and showed that the peptides entered through endocytosis and accumulated in endocytic vesicles, without necessarily entering the cytoplasm. To resolve this controversy and to extend the analyses to non-natural beta-peptide sequences, we studied the cytoplasmic and nuclear delivery of a fluorescein-labeled 9-residue sequence derived from the human immunodeficiency virus transactivator of transcription (TAT) peptide, TAT-(47-57), as well as a similarly labeled 12-residue beta-peptide, beta-(VRR)4, in live cells. Using fluorescence confocal microscopy, we show that when added to cells, both peptides are found in endocytic vesicles containing the transferrin receptor as well as in the cytoplasm and nucleus (TAT-(47-57)) or nucleolus (beta-(VRR)4). The cells were verified to be intact through all experimental procedures by demonstrating their ability to exclude propidium iodide. Endocytic entry of the peptides was blocked by the energy poisons sodium azide and 2-deoxyglucose, whereas staining of the nucleus (nucleolus), but not endocytic vesicles, was abrogated by treating the cells with ammonium chloride. Our observations are consistent with the proposal that TAT-(47-57) and beta-(VRR)4 enter cells by endocytosis and then exit an endosomal compartment to enter the cytoplasm by means of a mechanism requiring endosome acidification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Foldamers as versatile frameworks for the design and evolution of function
Goodman, C. M., Choi, S., Shandler, S., & DeGrado, W. F. (2007) · Nature Chemical Biology · doi:10.1038/nchembio876 · Cited by 899
Kam, N. W. S., Liu, Z., & Dai, H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503389 · Cited by 893
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408191101 · Cited by 822
A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides
Duchardt, F., Fotin‐Mleczek, M., Schwarz, H., Fischer, R., & Brock, R. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00572.x · Cited by 771
Cellular Uptake of Arginine-Rich Peptides: Roles for Macropinocytosis and Actin Rearrangement
Nakase, I., Niwa, M., Takeuchi, T., Sonomura, K., Kawabata, N., Koike, Y., Takehashi, M., Tanaka, S., Ueda, K., Simpson, J. C., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.010 · Cited by 752
Tat peptide-mediated cellular delivery: back to basics
BROOKS, H., LEBLEU, B., & VIVES, E. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.001 · Cited by 667
Arginine‐rich cell‐penetrating peptides
Schmidt, N., Mishra, A., Lai, G. H., & Wong, G. C. L. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.11.046 · Cited by 521
El-Sayed, A., Futaki, S., & Harashima, H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9071-2 · Cited by 465
Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers
Torchilin, V. P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.008 · Cited by 449
The design of guanidinium-rich transporters and their internalization mechanisms
Wender, P. A., Galliher, W. C., Goun, E. A., Jones, L. R., & Pillow, T. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.016 · Cited by 425
Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives
Patel, L. N., Zaro, J. L., & Shen, W.-C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9303-7 · Cited by 425
Cell-penetrating peptides and antimicrobial peptides: how different are they?
Henriques, S. T., Melo, M. N., & Castanho, M. A. R. B. (2006) · Biochemical Journal · doi:10.1042/bj20061100 · Cited by 412
Membrane-permeable arginine-rich peptides and the translocation mechanisms
FUTAKI, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.009 · Cited by 406
Cell-penetrating peptides as delivery vehicles for biology and medicine
Stewart, K. M., Horton, K. L., & Kelley, S. O. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b719950c · Cited by 381
Visualizing a Correlation between siRNA Localization, Cellular Uptake, and RNAi in Living Cells
Chiu, Y.-L., Ali, A., Chu, C.-Y., Cao, H., & Rana, T. M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.06.006 · Cited by 381
Peptides Containing β-Amino Acid Patterns: Challenges and Successes in Medicinal Chemistry
Cabrele, C., Martinek, T. A., Reiser, O., & Berlicki, Ł. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5010896 · Cited by 368
Nakase, I., Takeuchi, T., Tanaka, G., & Futaki, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.006 · Cited by 342
Jones, A. T. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00062.x · Cited by 315
Choonara, B. F., Choonara, Y. E., Kumar, P., Bijukumar, D., du Toit, L. C., & Pillay, V. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.07.006 · Cited by 311
Intracellular targeting of polymer-bound drugs for cancer chemotherapy
NORI, A., & KOPECEK, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.006 · Cited by 303
Torchilin, V. P. (2008) · Peptide Science · doi:10.1002/bip.20989 · Cited by 283
Fischer, R., Fotin‐Mleczek, M., Hufnagel, H., & Brock, R. (2005) · ChemBioChem · doi:10.1002/cbic.200500044 · Cited by 269
Ziegler, A., Nervi, P., Dürrenberger, M., & Seelig, J. (2005) · Biochemistry · doi:10.1021/bi0491604 · Cited by 266
Fretz, M. M., Penning, N. A., Al-Taei, S., Futaki, S., Takeuchi, T., Nakase, I., Storm, G., & Jones, A. T. (2007) · Biochemical Journal · doi:10.1042/bj20061808 · Cited by 257
γ-AApeptides as a New Strategy for Therapeutic Development
Nimmagadda, A., Shi, Y., & Cai, J. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666171107095913 · Cited by 21
Metadata
- Authors
- Potocky, T. B., Menon, A. K., & Gellman, S. H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 278
- Issue
- 50
- Pages
- 50188-50194
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2163021896
- Cited by
- 237
- References
- 0
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.